First published 9/28/2026, 2:28:15 AM · Last updated 9/28/2026, 2:28:15 AM

<scp>SOX1</scp> / <scp>PAX1</scp> Methylation for Triage of <scp>HPV</scp> ‐Positive Women in Cervical Cancer Screening: A Cohort Study

A Wiley-published journal article (19 Jan 2026) reports a cohort study evaluating SOX1 and PAX1 gene methylation as a triage approach for women testing positive for human papillomavirus in cervical cancer screening. The excerpt contains bibliographic details but no study results or participant details.

Categories: public-health, science-and-space, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

It concerns potential methods for triaging HPV-positive women during cervical cancer screening.

Sources

<scp>SOX1</scp> / <scp>PAX1</scp> Methylation for Triage of <scp>HPV</scp> ‐Positive Women in Cervical Cancer Screening: A Cohort Study

Report an issue